ORI Capital

Hong Kong, Hong Kong Founded: 2015 • Age: 11 yrs
A venture capital firm focused on early-stage biotech investments.

About ORI Capital

ORI Capital is a Financial Services company based in Hong Kong, Hong Kong founded in 2015. A venture capital firm focused on early-stage biotech investments. It operates on a Commission-Based model. ORI Capital offers products and services including Venture Capital Investment. Its focus areas include Finance, Venture Capital and Biotech Investments.

Company details

ORI Capital is a venture capital firm established in 2015, with funds dedicated to investing in innovative early-stage biotech companies worldwide. Investments are targeted in the fields of diagnostics, drug delivery, and therapeutics, specifically addressing high-mortality disease areas such as cancer, cardiovascular, and neurodegenerative diseases. The firm is based in Hong Kong and aims to support scientific advancements through strategic financial backing.

  • Headquarters Hong Kong, Hong Kong
  • Sectors
    Financial Services
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website ori-capital.com

Products & Services of ORI Capital

ORI Capital offers a comprehensive portfolio of products and services, including Venture Capital Investment.

Venture Capital Investment
Financial Services

Investments are made in early-stage biotech companies globally.

People of ORI Capital

15 people are tracked at ORI Capital (4 in leadership, 6 in board & advisors, 5 in team).

NameRoleGroup
Dicky To
PartnerLeadership
Simone Song
Founder & Senior PartnerLeadership
Kenneth Ho
Vice PresidentLeadership
Elaine Yang
DirectorLeadership
David S. Hong
AdvisorBoard & advisors
Qilong Ying
AdvisorBoard & advisors
Mark W. Feinberg
AdvisorBoard & advisors
Jack Szostak
AdvisorBoard & advisors
Paul Waring
AdvisorBoard & advisors
James Mulé
AdvisorBoard & advisors
Arnold Ching
Investment AnalystTeam
Danny Wong
Investment AnalystTeam
Anthony Su
Approach-Specific ScientistTeam
Jason Yau
Data EngineerTeam
Cathy Choi
Financial ControllerTeam
Premium access

Complete people profiles for ORI Capital

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about ORI Capital

ORI Capital was founded in 2015.

ORI Capital is a venture capital firm established in 2015, with funds dedicated to investing in innovative early-stage biotech companies worldwide. Investments are targeted in the fields of diagnostics, drug delivery, and therapeutics, specifically addressing high-mortality disease areas such as cancer, cardiovascular, and neurodegenerative diseases. The firm is based in Hong Kong and aims to support scientific advancements through strategic financial backing.

ORI Capital offers Venture Capital Investment.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available